160 related articles for article (PubMed ID: 18570928)
1. Valproic acid induces Notch1 signaling in small cell lung cancer cells.
Platta CS; Greenblatt DY; Kunnimalaiyaan M; Chen H
J Surg Res; 2008 Jul; 148(1):31-7. PubMed ID: 18570928
[TBL] [Abstract][Full Text] [Related]
2. Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells.
Greenblatt DY; Cayo MA; Adler JT; Ning L; Haymart MR; Kunnimalaiyaan M; Chen H
Ann Surg; 2008 Jun; 247(6):1036-40. PubMed ID: 18520232
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.
Greenblatt DY; Vaccaro AM; Jaskula-Sztul R; Ning L; Haymart M; Kunnimalaiyaan M; Chen H
Oncologist; 2007 Aug; 12(8):942-51. PubMed ID: 17766653
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.
Adler JT; Hottinger DG; Kunnimalaiyaan M; Chen H
Ann Surg Oncol; 2009 Feb; 16(2):481-6. PubMed ID: 19030935
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1.
Jang S; Jin H; Roy M; Ma AL; Gong S; Jaskula-Sztul R; Chen H
Cancer Med; 2017 Sep; 6(9):2142-2152. PubMed ID: 28776955
[TBL] [Abstract][Full Text] [Related]
6. Hesperetin, a potential therapy for carcinoid cancer.
Zarebczan B; Pinchot SN; Kunnimalaiyaan M; Chen H
Am J Surg; 2011 Mar; 201(3):329-32; discussion 333. PubMed ID: 21367373
[TBL] [Abstract][Full Text] [Related]
7. Notch signaling induces cell cycle arrest in small cell lung cancer cells.
Sriuranpong V; Borges MW; Ravi RK; Arnold DR; Nelkin BD; Baylin SB; Ball DW
Cancer Res; 2001 Apr; 61(7):3200-5. PubMed ID: 11306509
[TBL] [Abstract][Full Text] [Related]
8. Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1.
Ito T; Kudoh S; Ichimura T; Fujino K; Hassan WA; Udaka N
Hum Cell; 2017 Jan; 30(1):1-10. PubMed ID: 27785690
[TBL] [Abstract][Full Text] [Related]
9. A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma.
Mohammed TA; Holen KD; Jaskula-Sztul R; Mulkerin D; Lubner SJ; Schelman WR; Eickhoff J; Chen H; Loconte NK
Oncologist; 2011; 16(6):835-43. PubMed ID: 21632454
[TBL] [Abstract][Full Text] [Related]
10. Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.
Ning L; Jaskula-Sztul R; Kunnimalaiyaan M; Chen H
Ann Surg Oncol; 2008 Sep; 15(9):2600-5. PubMed ID: 18563491
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid, a histone deacetylase inhibitor, regulates cell proliferation in the adult zebrafish optic tectum.
Dozawa M; Kono H; Sato Y; Ito Y; Tanaka H; Ohshima T
Dev Dyn; 2014 Nov; 243(11):1401-15. PubMed ID: 25091230
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid exhibits different cell growth arrest effect in three HPV-positive/negative cervical cancer cells and possibly via inducing Notch1 cleavage and E6 downregulation.
Feng S; Yang Y; Lv J; Sun L; Liu M
Int J Oncol; 2016 Jul; 49(1):422-30. PubMed ID: 27176495
[TBL] [Abstract][Full Text] [Related]
13. Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.
Ning L; Greenblatt DY; Kunnimalaiyaan M; Chen H
Oncologist; 2008 Feb; 13(2):98-104. PubMed ID: 18305053
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors upregulate Notch-1 and inhibit growth in pheochromocytoma cells.
Adler JT; Hottinger DG; Kunnimalaiyaan M; Chen H
Surgery; 2008 Dec; 144(6):956-61; discussion 961-2. PubMed ID: 19041003
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
J Biol Chem; 2006 Dec; 281(52):39819-30. PubMed ID: 17090547
[TBL] [Abstract][Full Text] [Related]
16. Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer.
Fujino K; Motooka Y; Hassan WA; Ali Abdalla MO; Sato Y; Kudoh S; Hasegawa K; Niimori-Kita K; Kobayashi H; Kubota I; Wakimoto J; Suzuki M; Ito T
Am J Pathol; 2015 Dec; 185(12):3164-77. PubMed ID: 26482608
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy.
Hubaux R; Vandermeers F; Crisanti MC; Kapoor V; Burny A; Mascaux C; Albelda SM; Willems L
Eur J Cancer; 2010 Jun; 46(9):1724-34. PubMed ID: 20451370
[TBL] [Abstract][Full Text] [Related]
19. Chrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoids.
Somnay YR; Dull BZ; Eide J; Jaskula-Sztul R; Chen H
Cancer Gene Ther; 2015 Oct; 22(10):496-505. PubMed ID: 26403073
[TBL] [Abstract][Full Text] [Related]
20. The prognostic implications of Notch1, Hes1, Ascl1, and DLL3 protein expression in SCLC patients receiving platinum-based chemotherapy.
Tendler S; Kanter L; Lewensohn R; Ortiz-Villalón C; Viktorsson K; De Petris L
PLoS One; 2020; 15(10):e0240973. PubMed ID: 33104707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]